Meet Medrio Recap
June 7, 2022
How right-sized, efficient, and cost-effective trial technology solutions can get your devices to market faster. Intro A question we hear a lot from our medical
[gtranslate]
Medrio Blog
Using RTSM to Maximize Supply Chain Efficiency
June 7, 2022
A lot can go wrong in the lifecycle of an investigational product (IP). Medrio’s Randomized and Trial Supply Management (RTSM) expert, Ian Davison, shares proven
Right-Size Your Technology and Unlock New Efficiencies in Medical Device and Diagnostics Trials
April 29, 2022
With the constant pressures to do more with less, it can be overwhelming for medical device and diagnostics (MDD) researchers to plan out clinical trials
Meet Medrio Recap: How an Optimized RTSM Can Simplify Complexity and Help You Achieve Goals
April 20, 2022
What’s your top priority when selecting an RTSM solution? Is it a tool that helps you streamline operations to reduce exorbitant trial costs? Or perhaps
The Future of RTSM: Insights and Forecasting with RTSM-Expert, Ian Davison
April 5, 2022
By all expert accounts, 2022 is the year that we can begin seeing the societal shift from late-stage pandemic to early-stage endemic as the world
Think Paper is the Safe Choice for Your Studies? Think Again.
March 25, 2022
It’s 2022—the world is embracing digitalization on a mass scale, yet 76% of healthcare organizations admit to printing their consent forms on paper. Why does the clinical trials
It’s Time for Healthcare to #BreakTheBias
March 8, 2022
It’s 2022—over one hundred years have passed since the women’s suffrage movement; women make up more than half of the college-educated workforce; and the U.S. has our first female Vice President. But, many of us continue to ask, “Is that enough?” (Hint: the answer is a resounding NO!)
Why CTMS Is Critical As Trial Complexities Increase
November 9, 2021
The clinical trials industry is buckling under the weight of continuously growing complexities. Developing an interconnected clinical trials ecosystem will be essential to minimizing the
How to Sustain Clinical Trial Patient Engagement
September 8, 2021
The process of bringing a new treatment to market can be a long, arduous journey. On average, it takes ten years for a treatment to
How eSource Optimizes The Clinical Site Experience
September 8, 2021
Trial sites are a cornerstone of clinical research but are often overloaded with a myriad of complex, manual, and time-sensitive tasks. How can sites be
The Power of Patient-Centricity in Rare Disease Studies
September 7, 2021
Orphan drug discoveries promise unprecedented opportunities, as well as challenges. Unfortunately, research in the rare disease space presents some of the highest hurdles in medicine
Patient Data Privacy: What You Need to Know for Successful Clinical Trials
September 7, 2021
Protecting a patient’s personal health information (PHI) is integral to the success of clinical research. Although clinical researchers generally understand the need for PHI protection,
Can Your eClinical Empower Patients and Inform Stakeholders?
August 6, 2021
“People are experts in everyday living. Physicians are experts in clinical care. Technologies bring them together.” – Patricia Brennan, RN, Ph.D., FAAN, FACMI1 As clinical
Patient Engagement Strategies for Meaningful Outcomes
July 23, 2021
The narrative around patient engagement in clinical trials has remained largely unchanged in the last few decades. An alarming number of studies fail to meet
How to Enhance Your Patient Engagement Efforts Through Technology
July 7, 2021
Keeping patients enrolled and active in clinical research is one of the biggest obstacles to study success. But increased protocol complexity and rising costs make
4 Reasons Decentralized Trials Are Here to Stay
July 7, 2021
Long before the global pandemic, clinical trial sponsors were consumed with accelerating their studies and improving the trial experience for key stakeholders. Decentralization emerged as
5 Ways ePRO Boosts Patient Engagement
June 22, 2021
Collecting patient data is a necessary and critical step in clinical research. When done well, it can be fundamental in determining the safety and efficacy
How to Address Early Obstacles in Phase I
June 10, 2021
It’s no secret that getting new drugs or biological products approved by the FDA is a challenging task. The low rates at which drugs make
CSDD Report: Mid-Study Changes Cause Long Delays
June 8, 2021
Planned and unplanned mid-study changes add an average of 30 days to clinical trial timelines, according to a new study by the Tufts Center for
5 Signs Your EDC Takes Data Security Seriously
May 19, 2021
Technology continues to play a larger and more critical role in advancing clinical research. It has also brought challenges as regulatory bodies try to establish
Cybersecurity — A Concern In Clinical Research
May 16, 2021
The intersection of technology and healthcare has major implications, ranging from encouraging to ominous, for innumerable interested parties. Technological innovators and enthusiastic adoptees tout the
How to Strengthen Trial Retention Through Patient Education
May 1, 2021
According to a 2019 CISCRP study, 85% of the general public are willing to participate in clinical trial research. Yet, recruitment continues to plague the
The Difference Full-Service RTSM Can Make for Study Managers
April 29, 2021
The cost of clinical trials continues to rise as studies grow in complexity. A 2014 study by the Tufts Center for the Study of Drug
Key Considerations For a Successful RTSM Strategy
April 26, 2021
Developing a successful clinical trial supply chain relies on accurate forecasting. To understand which design elements and functionality are necessary to achieve your study goals,
Support Complex Randomization For Any Trial With RTSM
April 15, 2021
The increasing complexity of clinical study designs and unique treatment scenarios are making the randomization process for clinical trials more complicated. In fact, a Tufts
Thank Technology: Oncology’s Golden Age Is Here
March 20, 2021
To my mom, sister, father-in-law, and late aunt, I promise this: The 2020s will be a breakthrough decade for oncology. For me, cancer isn’t some
Diseases Don’t Discriminate. So Why Aren’t Clinical Trials More Diverse?
March 20, 2021
COVID-19 isn’t one tragedy, but many. An underreported tragedy is the outsized harm done to communities of color.In New York City — an early COVID-19
How Decentralized Trials Strengthen Your Participation Pool
March 16, 2021
Long before COVID-19, recruiting and retaining patients for clinical trials was a growing problem with 85% of all trials failing to recruit enough patients and
Hesitant to Embrace Decentralized Trials Because of Regulations?
February 13, 2021
As the COVID-19 pandemic first entered the states, the U.S. Food and Drug Administration (FDA) quickly recognized that the public health emergency would disrupt the
How Can Decentralization Help Oncology Trials?
February 2, 2021
Patient centricity is on the rise, and oncology trials have led the charge in that department. It could be said that decentralization is necessary for
How Adaptive Trial-Friendly EDC Benefits Oncology
January 29, 2021
Adaptive clinical trial design in oncology research represents an intersection of two major industry trends. One of these is the current prevalence of cancer clinical
Destination APAC: Australia, Oncology and Early Phase Clinical Trials
January 28, 2021
When most people think of clinical research in the Asia-Pacific (APAC), India and China are likely the first to come to mind. With the increasing
Making Precision Medicine Work
January 28, 2021
There’s no denying it: precision oncology holds great promise for the future of cancer treatment. The relatively new practice of targeting specific genetic biomarkers to
The Importance of Diversity in Clinical Trials
January 28, 2021
In the world of clinical trials, uniformity can be a dirty word. From blind use of placebos to dosage variation, incorporation of variables is an
2020 Has Changed the Face of Clinical Trials
December 1, 2020
And we likely won’t be putting the genie back in the bottle. When the pandemic hit the U.S. early this year and the first lockdowns
Design Your Trial for Success: Involve Patient Advocates Early
October 23, 2020
Trial Drop Out Rates Continue to Increase Trial drop-out rates continue to increase and some clinical trials grind to a halt due to low recruitment
The Future of Informed Consent
August 7, 2020
From eClinical data collection to telehealth to wearables and beyond, the clinical trials industry has seen a mass of technological advances over the past decade.
Virtual, Decentralized, Hybrid: What’s the Difference?
August 3, 2020
The clinical trial landscape is ever-changing. New technology and innovation have changed the way we look at clinical trial design. While we can agree that
Why Are Real-Time Edit Checks Important in Clinical Trials?
July 16, 2020
Modern clinical trials can be sprawling networks of clinics, people, and data. They can span borders and oceans. They utilize various communication channels. And they
What to Keep in Mind When Your eClinical Provider Gets Acquired
June 17, 2020
We comment a lot, on this blog, on the trends influencing the direction of clinical research and the eClinical technology industry. One trend that has
Is ePRO the Key to Avoiding Trial Delays During COVID-19?
May 27, 2020
At the onset of COVID-19, we began an impact survey to gauge how sponsors and CROs were reacting to the pandemic and how their trials
5 Essential Considerations for Global Clinical Trials
May 5, 2020
Over the past 10 years, the clinical trial industry has transformed dramatically. Globalization has taken off, giving rise to Contract Resource Organization (CRO) outsourcing, decentralized
Can EDC be Truly Affordable? In Short — YES
April 27, 2020
EDC Pricing Norms Are Murky Today, Electronic Data Capture (EDC) can take many forms. Just as different solutions offer different levels of functionality, there’s also
COVID-19: The Catalyst for Change
April 23, 2020
With the onset of COVID-19, sponsors and CROs are actively looking for ways to continue non-COVID-19 trials that have been left in a standstill due
How Dogs Are Helping Oncology Research
April 20, 2020
The symbiotic relationship between dogs and humans spans thousands of years. According to the Smithsonian, dogs were the first domesticated animal and likely have been
How COVID-19 is Causing the Industry to Rethink Paper vs ePRO
April 7, 2020
As the clinical trial industry focuses on finding a “new normal” during the COVID-19 pandemic, we are focused on how Medrio can assist in your
Patient Diversity and eClinical Vendor Selection
March 28, 2020
Regulators and many in the clinical research industry emphasize patient diversity, but how do contract research organizations (CROs) and sponsors achieve it? The US Food
How to Select the Ideal eClinical Service Provider for Oncology
March 20, 2020
What eClinical features do onology researchers need? According to a new analysis, oncology will account for the majority of clinical trials launched and completed in
eClinical Customer Service
March 12, 2020
With so much riding on the outcome of your research, you want to have reliable eClinical customer service behind you. When evaluating eClinical service providers,
Decentralized Trials: How Modern Tech Can Transform Your Trials
February 11, 2020
Harnessing technology standard in other highly regulated industries, decentralized trials are gaining traction and becoming a more significant part of our industry. They’re not a
Decentralized Trials: How to Get Started
January 29, 2020
Traditional clinical trial models place limitations on patients, with logistical and geographic barriers making it difficult to recruit, enroll, and retain a diverse participant pool.
The Rise of Decentralized Trials
November 19, 2019
In our webinar, Medrio Founder, Mike Novotny, and Covance Vice President and Global Head of Hybrid and Virtual Trials, Bola Oyegunwa, shared in-depth insight into
3 Ways Patient-Centricity Can Boost Clinical Trial ROI
October 26, 2019
There’s no question that patient recruitment, adherence, and retention are core concerns for researchers. A recent report cited there are now 40 million patients needed
5 Considerations When Choosing an eClinical Platform
September 12, 2019
Digital technology is now completely intertwined with our lives. It’s transformed the way we communicate personally and professionally and has revolutionized industries from business to
3 Reasons Why eSource Is a Must for Global Trials
July 10, 2019
What Is eSource? Source data is the initial data recording, and eSource is any source data that is recorded electronically with the goal of producing
4 Innovations That Are Streamlining Trials Today
June 21, 2019
Clinical researchers deserve a lot of credit. Bringing a new medical product to market today means navigating a whole host of challenges, from patient recruitment
QT Ultrasound Discusses Paradigm Shift in Breast Cancer Detection
June 18, 2019
Lise Lindquist is a Clinical Data Manager at QT Ultrasound, a company using Medrio to collect critical data to support their clinical research and product
Patient Centricity: Greater Value for Participants and Beyond
May 30, 2019
It’s no secret that patient recruitment and retention remain among the most significant hurdles in clinical trials. As research becomes more globalized and sophisticated, many
The Future of Pharma R&D — And Why New Tech is Essential
May 30, 2019
The stakes are high: large risks and the potential for huge rewards are deeply rooted in pharmaceutical research and development. Each year billions are spent
Adaptive Trials: Is Your Study Equipped To Adapt?
May 20, 2019
Imagine, for a moment, you’re a data manager overseeing a Phase I study. Your endpoints are set, your database built and deployed, and your data
How A Problematic Database Project Inspired Me To Revamp eClinical Software
May 17, 2019
Early in my career, I built custom databases for whoever needed them. It was the mid-90s when it was a big deal to get a
Avoiding Headaches In Today’s Complex Phase I Landscape
May 16, 2019
Statistics suggest that Phase I clinical trials, while by no means free of challenges, are more manageable than later phases. They tend to take less
Regulatory Shifts for Medical Device in APAC
May 15, 2019
With MDR right around the corner, organizations conducting medical device clinical research are working overtime to prepare for the massive regulatory shifts about to go
Thought Leader Spotlight: Jim Nance on Adaptive Clinical Trial Design
May 8, 2019
Anyone with more than a few years’ experience in the clinical research industry has been witness to major industry shifts, both in the way clinical
5 Patient Engagement Innovations in Healthcare and Clinical Research
March 23, 2019
Patient engagement isn’t just a buzzword anymore. With the massive transformation that clinical trials have gone through over recent years, it has emerged at the
Data Quality in Your eClinical System — What’s at Stake for a CRO?
September 15, 2018
If you know Medrio — if you’ve interacted with us at industry conferences, perused our site, or spend a good amount of time on this
Clinical Trial Acronyms and Abbreviations
August 3, 2018
When we talk to people who are new to our industry, one of the toughest things for them to wrap their heads around is the
3 Early Obstacles in Phase I Clinical Trials, And How to Address Them
April 15, 2018
Anyone with an involvement or interest in clinical research is likely to be aware of the challenges sponsors face in getting their compounds approved by
Optimizing the EDC Onboarding Process
January 29, 2018
Let’s say you’ve gone through a rigorous selection process to pick your EDC, deployed it, and are ready to train your staff. Your data management
The Road to a Smarter eClinical Workflow
December 19, 2017
At long last, the eClinical industry is showing signs of evolving beyond the challenges that stem from traditional pricing models and workflows. Here’s a scenario you may
Subscribe To Our Newsletter
